On January 25, 2026, Yicheng City held the municipal Economic Work Conference and Three-level Cadres Conference. The commending ceremony recognized advanced collectives and individuals who made outstanding contributions to the city’s economic and social development in 2025.Hubei Tianshu Pharmaceutical Co., Ltd. (Tianshu Pharmaceutical) was awarded the honorary title of "Advanced Collective for County Economic Development 2025" for its outstanding performance and remarkable contributions in industrial upgrading, R&D innovation and county empowerment, standing as a backbone force driving economic growth in Yicheng’s biomedical industry. Liu Yunlong, General Manager of Tianshu Pharmaceutical, attended the conference as the enterprise representative and received the award on stage.
Learn More
Recently, the near-term greenhouse gas (GHG) emission reduction targets of Hubei Tianshu Pharmaceutical Co., Ltd. (Tianshu Pharmaceutica) have been successfully validated by the Science Based Targets initiative (SBTi). This fully demonstrates the company's determination and confidence in actively responding to climate change and firmly practicing the ESG philosophy, marking a solid step forward for Tianshu Pharmaceutical on the path of low-carbon and sustainable development.
Learn MoreRecently, Hubei Tianshu Pharmaceutical Co., Ltd. (referred to as "Tianshu Pharmaceutical") has received the Approval Notice for Marketing Application of Chemical Active Pharmaceutical Ingredients (APIs) issued and verified by the National Medical Products Administration (NMPA). This marks the official approval for marketing of the company's first generic drug API — Vonoprazan Fumarate (Registration No.: Y20240000846), which is a milestone in the company's development.
Learn More
Recently, Hubei Tianshu Pharmaceutical Co., Ltd. Tianshu Pharmaceutical) and Yunzi Enterprise Management Consulting (Hebei) Co., Ltd. (Yunzi Pharmaceutical) held a strategic cooperation signing ceremony and project kick-off meeting. The two parties officially entered into strategic cooperation to comprehensively elevate Tianshu Pharmaceutical's quality management system, laying a solid foundation for the company to further expand international markets, boost product exports, and meet certification standards of high-end markets including the US, the EU and Japan.
Learn More
On October 23rd, Hubei Tianshu Pharmaceutical Co., Ltd. (Tianshu Pharmaceutical) organized a series of autumn activities for corporate culture construction, aiming to continuously deepen the construction of corporate culture, enhance team cohesion and employees' sense of belonging, and enrich employees' spiritual and cultural life. This activity innovatively adopted the form of "batches and multiple scenarios" to ensure that every employee could participate and share the achievements and joys of the company's development.
Learn More
To deepen the strategic synergy and cultural integration between Tianshu Pharmaceutical and Vcare PharmaTech Headquarters, and enhance the comprehensive capabilities of management personnel, over 20 middle and senior managers from Tianshu Pharmaceutical traveled to Nanjing on August 9-10 to conduct a two-day special training and exchange activity with more than 110 personnel from Vcare PharmaTech's R&D Headquarters.
Learn More